Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria

BACKGROUND: The RECIST guidelines are commonly used in phase II and III clinical trials. The correct definition of response can be controversial in some situations, as in the case we describe. CASE PRESENTATION: A 43 year-old man with advanced gastric cancer was enrolled in a phase II trial where he...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoroso, Vito, Pittiani, Frida, Grisanti, Salvatore, Valcamonico, Francesca, Simoncini, Edda, Ferrari, Vittorio D, Marini, Giovanni
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896169/
https://www.ncbi.nlm.nih.gov/pubmed/17540044
http://dx.doi.org/10.1186/1471-2407-7-94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896169/
https://www.ncbi.nlm.nih.gov/pubmed/17540044
http://dx.doi.org/10.1186/1471-2407-7-94

Ejemplares similares